Katrina Abuabara, MD, FAAD
SESSIONS
U055 Practical Considerations for Systemic Treatment of Atopic Dermatitis in Adults
Mar 9, 2025
•
8:00 AM - 12:00 AM
•
W311A
DISCLOSURES
Amgen – Consultant (1099 relationship)(Fees); Apogee Therapeutics – Consultant (1099 relationship)(Fees); Astria Therapeutics – Consultant (1099 relationship)(Fees); Cedar Healthcare – Stockholder(Stock); Eli Lilly – Advisory Board(Honoraria); Incyte – Consultant (1099 relationship)(Fees); Medidata – Consultant (1099 relationship)(Fees); Nektar Therapeutics – Consultant (1099 relationship)(Fees); Sanofi – Consultant (1099 relationship)(Fees); TARGET Pharma – Advisory Board(Fees);